Scientists Take Aim at Illicit Supply Chain Networks of Fake Medications

Office of Public Affairs and Communications

For many people in developing countries, the struggle for access to health care comes with a risk. Those patients can fall victim to falsified medications that fail to treat their conditions, with the potential to cause harm and, in some cases, death.

Now, a new study will take aim at illicit supply chain operations to improve detection of falsified medications before they harm patients. The project is a collaboration between the University of Notre Dame and Northwestern University.

The study is one of nine projects awarded funding through the National Science Foundation’s Early-Concept Grants for Exploratory Research (EAGER) focusing on disrupting illicit supply chain networks.

Scientists Take Aim at Illicit Supply Chain Networks of Fake Medications

More Like This

The End of Free Speech is the End of Science

UFOs and Human Security: An Autoimmune Theory (or How Things Could Fall Apart)

Literary Celebs: Amalia Guglielminetti, Guido Gozzano and the Price of Fame

Lessons for the West from a Small African Country

Alumnae Career Panel: Women in Sports Tech, Youth Sports, and Sports Media

Kirk Doran, Professor of Economics

Caring for Women and Children: Practitioner & Practice

Notre Dame, Our Mother – Caring for Women and Children After Dobbs

To Console, To Raise, To Give Hope – The Vocation of the Catholic Physician Today

Notre Dame researchers present latest findings and innovations to nation’s second highest-ranking military officer

Subscribe to our Newsletter